Abstract
The effect of captopril on tumour growth was examined in a xenograft model of human renal cell carcinoma (RCC). Inoculation of the human RCC cell line SN12K-1 (10(6) cells) under the left kidney capsule of severe combined immunodeficient (SCID) mice resulted in the growth of large tumours, with an increase in weight of the inoculated kidney of 3.69+/-1.63-fold (mean+/-s.d.) when compared with the contralateral normal kidney. In mice treated with captopril (19 mg kg(-1) day(-1) or 94 mg kg(-1) day(-1) administered in the drinking water), there was a significant dose-related reduction in tumour development; the tumour bearing kidneys weighed 1.9+/-0.42 and 1.55+/-0.42 times the normal kidneys, respectively (P< 0.05 compared with untreated animals). In vitro, captopril at clinically achievable doses (0.1-10 microM) had no significant effect on the incorporation of [3H]thymidine into SN12K-1 cells. Thus, this highly significant attenuation by captopril of in vivo tumour growth does not appear to be due to a direct effect on the proliferation of the tumour cells. Further studies are required to determine the mechanism of inhibition of tumour growth by captopril, in particular to evaluate the role of angiotensin II in this process.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hii, SI., Nicol, D., Gotley, D. et al. Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma. Br J Cancer 77, 880–883 (1998). https://doi.org/10.1038/bjc.1998.145
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.145
This article is cited by
-
Predictors of Squamous Cell Carcinoma in High-Risk Patients in the VATTC Trial
Journal of Investigative Dermatology (2013)
-
Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of prostate cancer in the Han population of China
Medical Oncology (2012)
-
Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
BMC Cancer (2010)
-
Changes in the renin angiotensin system during the development of colorectal cancer liver metastases
BMC Cancer (2010)
-
Reinventing the ACE inhibitors: some old and new implications of ACE inhibition
Hypertension Research (2010)